Welcome to our dedicated page for Vext Science news (Ticker: VEXTF), a resource for investors and traders seeking the latest updates and insights on Vext Science stock.
Vext Science, Inc. (VEXTF) is a vertically integrated U.S. cannabis operator with cultivation, manufacturing, and retail operations in Arizona and Ohio. This page provides investors and industry observers with direct access to official company announcements, including earnings reports, regulatory updates, and strategic initiatives.
Track Vext Science's progress through press releases detailing operational expansions, product innovations under its Vapen brand, and compliance milestones in medical and adult-use markets. Our curated collection ensures timely access to material developments affecting the company's position as a leader in THC concentrate production and cost-efficient facility build-outs.
Key updates include manufacturing advancements, retail dispensary openings, licensing achievements, and financial performance. Bookmark this page to monitor how Vext Science leverages its fully integrated model to maintain quality control across its supply chain while adapting to evolving cannabis regulations.
Vext Science (VEXTF) reported strong Q4 2024 financial results, marking its strongest operating quarter in recent years. Revenue reached $10.2 million in Q4 2024, up 13% quarter-over-quarter, driven by Ohio adult-use sales and Arizona operations. Adjusted EBITDA grew significantly to $3.2 million (compared to $0.5 million in Q4 2023), while cash flow from operations turned positive at $4 million.
The company received approval from Ohio's Division of Cannabis Control to acquire Big Perm dispensaries in Athens and Jeffersonville. This expansion will double Vext's Ohio retail footprint to four locations. Additionally, Vext secured a provisional license for a fifth dispensary in Portsmouth, Ohio, expected to open in Q2/Q3 2025. The company aims to reach Ohio's dispensary license cap of eight locations by early 2026.
In Arizona, despite a 25% decline in statewide per-store sales, Vext maintained market share through effective retail traffic management and improved yields at its Eloy cultivation facility.
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q4 and fiscal 2024 financial results announcement for March 31, 2025, before market open.
The company will host a conference call and webcast on the same day at 8:00 AM ET to discuss the quarterly and full-year 2024 results. Participants can join via phone using dial-in numbers +1-647-849-3159 or 1-833-752-3966 (Conference ID: 10197749). A replay will be available until April 14, 2025, using playback number 5786741.
Vext Science (VEXTF) has relocated and expanded its Herbal Wellness Center dispensary in Jackson, Ohio, doubling its retail footprint. The new location features an 8,350 square foot space, including 4,500 square feet for retail operations and a drive-thru window for improved customer convenience.
The company operates a vertically integrated business in Ohio, including a Tier I cultivation facility, a manufacturing facility, and two operational dispensaries in Jackson and Columbus. Vext is pursuing expansion to reach Ohio's maximum limit of eight dispensaries, with plans to add locations in Athens, Jeffersonville, and Portsmouth through its Ohio Expansion Transaction, expected to close in Q1 2025.
The company has received approval to develop three additional dual-use dispensaries under the DCC's 10(B) license program. The new Jackson location is leased with a purchase option, offering flexibility for future growth and potential sublease opportunities to offset occupancy costs.
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, announced the voting results from its annual general meeting held on December 13, 2024, in Vancouver. Shareholders demonstrated strong support for all matters presented in the management information circular, with each resolution passing with over 98% approval. The voting represented 73.45% of the total issued and outstanding shares of the company.
Vext Science (VEXTF) has secured a provisional license for its fifth cannabis dispensary in Portsmouth, Ohio, strengthening its retail presence in this -license market. The dispensary is expected to begin operations in Q2 or Q3 2025, pending regulatory approvals. The company acquired the associated real property through a $350,000 mortgage at 10% annual interest over 15 years.
Vext currently operates a Tier I cultivation facility, a manufacturing facility, and two retail dispensaries in Jackson and Columbus. The company aims to reach Ohio's state license cap of eight dispensaries through previously announced acquisitions and additional 10(B) licenses. The Portsmouth location, situated along the Ohio River, represents a strategic expansion in southern Ohio.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has expanded its engagement with Zuanic & Associates through a Revised Services Agreement. Under the new agreement, Zuanic will provide advisory, research, and investor relations services to Vext for an initial twelve-month term starting October 1, 2024. The services will be provided for a monthly cash fee not exceeding US$7,000. Zuanic, an arm's length financial consulting and research advisory firm based in New Jersey, will deliver these services through various mediums and platforms.
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has distributed Meeting Materials for its upcoming Annual General Meeting scheduled for December 13, 2024. The materials include the Management Information Circular, Notice of Meeting, and proxy form. Due to the Canada Post strike, shareholders can access electronic copies through the company's website, SEDAR+ profile, or by email request. Registered shareholders must submit proxy forms 48 hours before the meeting, excluding weekends and holidays.
Vext Science reported Q3 2024 financial results with revenue of $9.0 million and Adjusted EBITDA of $2.9 million. The company saw a 14.2% sequential increase in consolidated retail sales, driven by adult-use sales growth in Ohio and market share gains in Arizona. Q3 performance showed significant improvement with Adjusted EBITDA margin reaching 32.0%, up from 12.9% in Q2 2024. The company is positioned to expand its Ohio footprint to reach the state dispensary license cap of 8, with new locations planned to open throughout 2025 and early 2026.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q3 2024 financial results release for November 21, 2024, before market open. The company will host a conference call and webcast on the same day at 8:00 a.m. ET. A replay of the conference call will be available until December 5, 2024, and the webcast will be accessible through Vext's investor website.
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has entered into a Services Agreement with PartnerCap Securities, The agreement, effective September 23, 2024, engages PartnerCap to provide services including Investor Relations Activities such as research and publication services.
The initial term of the agreement is six months, with automatic three-month renewals thereafter. Vext will pay PartnerCap a cash fee of US$18,000 for the initial term and US$9,000 for each subsequent three-month renewal. Additional fees may apply for services beyond Investor Relations Activities.
PartnerCap is a FINRA registered brokerage firm based in Bluffton, South Carolina, and operates at arm's length from Vext.
FAQ
What is the current stock price of Vext Science (VEXTF)?
What is the market cap of Vext Science (VEXTF)?
